Showing results (291-300 of 6,146) with videos related to
Sort By:
Pageof 615
Nature Medicine|May 16, 2019
Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1Hanadie Yousef, Cathrin J Czupalla, Davis Lee, et al.Nature Medicine|April 25, 2018
Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancerJacqulyne P Robichaux, Yasir Y Elamin, Zhi Tan, et al.Nature Medicine|July 25, 2018
Cytotoxic CD8+ T cells recognize and kill Plasmodium vivax-infected reticulocytesCaroline Junqueira, Camila R R Barbosa, Pedro A C Costa, et al.Nature Medicine|July 25, 2018
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivoAnila K Madiraju, Yang Qiu, Rachel J Perry, et al.Nature Medicine|May 9, 2018
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockadeJianfeng Shen, Zhenlin Ju, Wei Zhao, et al.Nature Medicine|May 23, 2018
Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndromeNorifumi Shioda, Yasushi Yabuki, Kouya Yamaguchi, et al.Nature Medicine|July 18, 2018
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenibLynn Quek, Muriel D David, Alison Kennedy, et al.Nature Medicine|August 8, 2018
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumabDavid R Gandara, Sarah M Paul, Marcin Kowanetz, et al.Nature Medicine|October 8, 2021
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromesSushree S Sahoo, Victor B Pastor, Charnise Goodings, et al.Nature Medicine|October 29, 2021
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trialMichael E Nassif, Sheryl L Windsor, Barry A Borlaug, et al.Pageof 615